Expert Commentary

In the latest report from the WHI, the data contradict the conclusions

Author and Disclosure Information



Related Article: Update: Menopause Andrew M. Kaunitz, MD (May 2010)

We need to look at the totality of the data on menopausal HT, evaluate our patients individually, treat those who are truly hormonally deficient and suffering, and counsel them that many of the harms linked to HT have been exaggerated.

The pendulum is finally swinging back toward a more balanced assessment of the benefits and risks of HT, indicating that it may be appropriate for primary prevention of cardiovascular disease, osteoporosis, and type 2 diabetes—and thus can potentially expand the lifespan. It’s up to us to communicate this fact to our patients.

Share your thoughts on this article or on any topic relevant to ObGyns and women’s health practitioners. Tell us which topics you’d like to see covered in future issues, and what challenges you face in daily practice.
We will consider publishing your letter and in a future issue.
Send your letter to:
Please include the city and state in which you practice.
Stay in touch! Your feedback is important to us!

Next Article:

VIDEO: Moderate exercise reduced women’s stroke risk

Related Articles